Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Human African trypanosomiasis]

M Dumas1, B Bouteille

  • 1Institut d'Epidémiologie Neurologique et de Neurologie Tropicale, Faculté de Médecine, Limoges, France.

Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability.

Antimicrobial agents and chemotherapy·2021
Same author

Antifungal susceptibility testing practices in mycology laboratories in France, 2018.

Journal de mycologie medicale·2020
Same author

Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

[Epidemiology of cysticercosis and neurocysticercosis].

Medecine et sante tropicales·2014
Same author

[About an autochtonous case of neurocysticercosis in Mali].

Bulletin de la Societe de pathologie exotique (1990)·2009
Same author

[Neurology in developing countries].

Medecine tropicale : revue du Corps de sante colonial·2009
Same journal

[Saltatory propagation of the nerve impulse in the Akiyama nerve].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same journal

[Nycthemeral variations of the urinary excretion of acid mucopolysaccharides and of the blood levels of seromucoids. Influence of a hypophysial or adrenal factor].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same journal

[Statistical distribution of the ABO blood groups in the population of the Bas-Rhin, and comparison with those of adjacent departments].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same journal

[Method of measuring the variations in peripheral vascular capacity by the use of human serum albumin labeled with I-131].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same journal

[Action of nialamide on coronary circulation. The influence exerted by a serotonin antagonist on the action of nialamide and of iproniazid].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
Same journal

[Pharmacodynamics of the human round ligament. Action of acetylcholine, esterine, adrenaline and oxytocin].

Comptes rendus des seances de la Societe de biologie et de ses filiales·2014
See all related articles

Human African trypanosomiasis (HAT), or sleeping sickness, is a parasitic disease transmitted by tsetse flies. Early diagnosis and treatment are crucial as the parasite invades the central nervous system (CNS), leading to severe neurological damage and death.

Area of Science:

  • Medical Parasitology
  • Neuroimmunology
  • Tropical Medicine

Context:

  • Human African trypanosomiasis (HAT) is a vector-borne parasitic disease endemic to sub-Saharan Africa.
  • Caused by Trypanosoma brucei, HAT progresses to the central nervous system (CNS), causing severe neurological impairment and often death.
  • Current diagnostic methods for CNS involvement are challenging, complicating treatment decisions.

Purpose:

  • To elucidate the complex pathophysiology of Human African trypanosomiasis, focusing on its progression to the central nervous system.
  • To highlight the mechanisms of parasite immune evasion and host inflammatory responses within the CNS.
  • To underscore the diagnostic difficulties and therapeutic challenges associated with advanced HAT.

Summary:

  • HAT parasites invade the CNS, triggering an inflammatory cascade involving cytokines and immune cells, leading to demyelination and neurological dysfunction.

Related Experiment Videos

  • Trypanosomes evade the host immune system through antigenic variation of their surface glycoproteins.
  • The diagnosis of CNS involvement is difficult, impacting the choice of treatment, with melarsoprol being effective but toxic.

    • Impact:

    • Understanding the CNS pathology is critical for developing effective diagnostic tools and targeted therapies for HAT.
    • Identifying novel drug targets based on parasite biochemistry could lead to safer and more effective treatments.
    • Improved management strategies are needed to combat the high mortality and morbidity associated with late-stage HAT.